ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Merus NV

Merus NV (2GH)

42.20
0.80
(1.93%)
Closed 07 December 8:00AM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
42.20
Bid
41.80
Offer
42.80
Volume
0.00
0.00 Day's Range 0.00
21.40 52 Week Range 58.50
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1-2.3148148148143.2474319244.19451697DE
4-7.8-15.65051.540.411744.74603537DE
12-3-6.6371681415945.251.540.412747.17167127DE
26-6-12.448132780148.257.540.415948.57608533DE
5219.283.47826086962358.521.39999917344.34418355DE
15618.477.310924369723.858.51916742.00023485DE
26018.477.310924369723.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M
A6NAsana Inc
21.00 €
(43.84%)
19.08k
NL8Genesis Ai Corp
0.0214 €
(40.79%)
13.33k
RQ0DWave Quantum Inc
4.814 €
(34.92%)
1.15M
K8DWellfield Technologies Inc
0.0342 €
(34.65%)
30.8k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
M0YNMynaric AG
1.40 €
(-72.66%)
303.13k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
D7GNel ASA
0.2625 €
(-1.69%)
4.24M
LK1Lake Resources
0.029 €
(-6.75%)
2.32M
TUI1Tui AG
8.40 €
(1.11%)
2.17M
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M

Discussion

View Full Feed
Release us Release us 10 minutes ago
DOGE will grill FHFA
https://www.youtube.com/watch?v=RkmuI5W694o
FNMA
SilkRoad SilkRoad 16 minutes ago
KBLB has a customer that will be buying that first specific amount of silk. That’s why a specific amount of silk needs to be made before they will sell it. It’s my belief the customer either said we need a minimum of X amount to run through to be able to make X product, or they said we normally bu
KBLB RKLB
eagle8 eagle8 17 minutes ago
flipper,

Since NWBO is going to start with DCvax-Direct again in January, I strongly suspect that they have found an adequate replacement for Tice BCG by now.
Any ideas?

Thanks in advance.
BCG NWBO
LoveThemStocks LoveThemStocks 19 minutes ago
After watching that video a second time, she seems to be a terrific CFO who wants to sprint and not take her time growing. In this business of producing a future battery that all other companies are also trying to produce, you can't take your time when the competition is also very fierce, YOU HAVE T
AMPX
Guzzi62 Guzzi62 21 minutes ago
Thanks George,

TTTav66 is very good at digging stuff up.

Professor Audrey Gabelle is a very clever lady, it seems.

336 Publications and 7,811 Citations

She is likely very positive on the 2/3 AD trial results as well, or she would not bothe
AVXL
sab63090 sab63090 21 minutes ago
Thanks, George....you certainly DO provide information that we appreciate!

As an aside: I noticed that someone on another board reported that earlier...but I'm just now checking out other places...some would have missed it if you had not reported it though...
AVXL
lakers17 lakers17 22 minutes ago
PIN hit $2.01. Hopefully more to come. 158 million dollar market cap and many are saying it could hit a billion which means it could go over $10. I can always dream. I bought at .17 and passed at .06 on it.
BurgerKing82 BurgerKing82 24 minutes ago
If the volume comes back here... It can fly
GRLT
sab63090 sab63090 24 minutes ago
Steady T
You changed my mind! I'm with you on this although I did recommend Hosai's post!

Appreciate your deduction!
AVXL
walterc walterc 28 minutes ago
if you are 20 years in this stock and you have just a little bit of investing brains you should have a very decent profit .
LWLG
floblu14 floblu14 30 minutes ago
A humongous, short squeeze is a comin'. Well-deserved, I might add. :-)
ENTA
sab63090 sab63090 30 minutes ago
Yes, Mike he did say that based on the history of Missling consistently NOT keeping promises,

Missling's board did award him with newly printed options on a lower hanging fruit (application before acceptance)....I'm not trying to take sides since you know I am long, but we all make e
AVXL
LVerstee LVerstee 32 minutes ago
The latest photo uploaded by company themselves of https://yip.su/laxmiprasad.png Laxmi Prasad . So you are not infringing on any assumed privacy rights.
ITUP
GREGG THE GREEK GREGG THE GREEK 32 minutes ago
Fantastic way to end the week for RDAR.


Let's see that 01+++


RDAR
RDAR
Bruno2 Bruno2 37 minutes ago
Nikola Motors Assembly Plant December 6th, 2024 update

https://youtu.be/0gDmcLaPQ_Q
NKLA
sab63090 sab63090 37 minutes ago
These compensation packages are very rewarding and without out of pocket risk and no tax consequences (currently)...like a guy on the craps table betting on making an easy point...8 or 9 on the rollout.

He's getting a lot of LEVERAGE to wealth if he's correct, but I don't think he des
AVXL
LVerstee LVerstee 43 minutes ago
Sure. I will post it in a minute.
ITUP
floridaboy floridaboy 47 minutes ago
I did stick a bid in yesterday morning for 15 million @ .0003. If anybody runs out of patience while we wait, I will take'm...
SAPX
SilkRoad SilkRoad 48 minutes ago
KBLB video has 15,100 combined views on the 247 Market News and Kraig Biocraft Laboratories YouTube pages. Growing awareness is good for KBLB and all longs.

Kong on.
KBLB
sab63090 sab63090 50 minutes ago
kund
I have to totally AGREE with you on this!

Just a filing to slip in some more crease before acceptance

Greed comes to mind
AVXL
lovethatgreen lovethatgreen 50 minutes ago
Listening to what nick says will lose you money guaranteed .
I listened to him from .40 down to 15 and then I finally stopped listening.
Now the bid is .06
He won't give you much of a bedtime story imo.
No one is going to buy back with the current status.
BLFR
BurgerKing82 BurgerKing82 51 minutes ago
At some ,It's a Buy???
MJNA
mascale mascale 52 minutes ago
Among the literate, timeline support would be said literacy=based on its face. Fictionary-based commentary would also be said unable to create the inference..
HIRU
Ranb2khz Ranb2khz 52 minutes ago
Go Tell it on the Mountain – Big Daddy Weave (lyrics)

[yt]QpjCRnlWyZE[/yt]

https://www.youtube.com/watch?v=QpjCRnlWyZE






Your Recent History

Delayed Upgrade Clock